Dr. Bernice Morrow's lab at the Albert Einstein College of Medicine focuses on understanding how specific genes influence the development of the heart, particularly in relation to congenital heart diseases linked to a genetic condition known as 22q11.2 deletion syndrome. They use advanced techniques to study molecular mechanisms in developing mouse models, aiming to uncover how cell fate decisions are made during heart formation. By identifying and manipulating genetic pathways, the lab seeks to provide insights that could help in treating heart defects associated with this condition.

Dr. Meelad Dawlaty's lab focuses on understanding how specific enzymes, known as Tet enzymes, play a crucial role in the formation of blood cells during embryonic development. They study how these enzymes help regulate the transition of cells from one type to another, specifically from endothelial cells to blood progenitor cells. By exploring the molecular mechanisms behind these processes, the lab aims to inform potential treatments for blood disorders and improve methods for generating blood cells in the lab for clinical applications.